Literature DB >> 16916424

Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.

Norman L Keltner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916424     DOI: 10.1111/j.1744-6163.2006.00073.x

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


× No keyword cloud information.
  2 in total

Review 1.  The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.

Authors:  Baptiste Pignon; Chloé Tezenas du Montcel; Louise Carton; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2017-11-07       Impact factor: 5.285

2.  Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?

Authors:  Esther Ching-Lan Lin; Wen-Chuan Shao; Hsin-Ju Yang; Miaofen Yen; Sheng-Yu Lee; Pei-Chun Wu; Ru-Band Lu
Journal:  Metab Brain Dis       Date:  2014-07-19       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.